BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for March 18, 2022

March 18, 2022
New hires and promotions in the med-tech industry, including: apsulomics, Integer, Neupath, Venus Medtech.
Read More

Appointments and advancements for March 17, 2022

March 17, 2022
New hires and promotions in the biopharma industry, including: Acelyrin, An2, C4, Cormedix, Enveda, Gennao, Inmed, Ring.
Read More

Appointments and advancements for March 17, 2022

March 17, 2022
New hires and promotions in the med-tech industry, including: Akili, Brain Scientific, Capsulomics, Medtronic, Seegene, Seer.
Read More

Appointments and advancements for March 16, 2022

March 16, 2022
New hires and promotions in the med-tech industry, including: Augmedics, Binx Health, Biosig Technologies, Bruker, CS Genetics, Quit Genius, Sight Sciences, Summerbio.
Read More

Appointments and advancements for March 16, 2022

March 16, 2022
New hires and promotions in the biopharma industry, including: Alltrna, Denali, Grey Wolf, Halozyme, Immunic, Immuron, Kallyope, Olatec, Radius, Snipr Biome, Visus.
Read More

Appointments and advancements for March 15, 2022

March 15, 2022
New hires and promotions in the biopharma industry in Asia-Pacific, including: Adlai Nortye, Aslan.
Read More

Appointments and advancements for March 15, 2022

March 15, 2022
New hires and promotions in the med-tech industry, including: Ambu, Breg, Ortho Regenerative Technologies.
Read More

Appointments and advancements for March 15, 2022

March 15, 2022
New hires and promotions in the biopharma industry, including: Adlai Nortye, Adrenomed, Aslan, Avadel, Awakn, Coherus, Cortexyme, Epizyme, Etcembly, Garuda, Mablink, Mineralys, Neoleukin, Neurobo, Neuraxpharm, Ortho Regenerative, Shoreline, Spruce, Surface Oncology.
Read More

Appointments and advancements for March 14, 2022

March 14, 2022
New hires and promotions in the med-tech industry, including: Illumina, Iqvia, Irhythm.
Read More

Appointments and advancements for March 14, 2022

March 14, 2022
New hires and promotions in the biopharma industry, including: Achieve, Applied Molecular Transport, Camp4, Crinetics, Curie, Elevation Oncology, Evaxion, Genmab, Illumina, Kamada, Karyopharm, Melinta, Sellas, Veraxa, Verona.
Read More
Previous 1 2 … 197 198 199 200 201 202 203 204 205 … 322 323 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 28, 2026.
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Cerebral aneurysm illustration

    Grace Therapeutics hits CRL setback with GTx-104 despite positive trial

    BioWorld
    Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
  • Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists

    BioWorld Science
    Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing